Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + fentanyl versus midazolam + fentanyl for bronchoscopy sedation
IRCT20141209020258N76Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexmedetomidine, midazolam and fentanyl in sedation (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Sedation effect and Patient satisfaction. Started Jan 2018; status: completed.
02
Drugs
dexmedetomidinemidazolamfentanyl
03
Conditions
sedation
Beyond the preview
Go deeper on IRCT20141209020258N76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N76.